🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy liver enzyme journey — looking for input Page 7

My liver enzyme journey — looking for input

Dr.KarenChen Tue, Jul 9, 2024 at 5:54 PM 39 replies 2,351 viewsPage 7 of 8
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Jul 14, 2024 at 11:06 PM#31
DanielChem_CHI said:
If you are going to change something, change one thing and give it long enough to express itself.

That reframing is the part I needed.

Last edited: Jul 15, 2024 at 12:06 AM
37 10matt_MKE, Dr.ReproEndo, lucas_SP_BR and 34 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Jul 15, 2024 at 7:36 AM#32

Clinical perspective, offered as context rather than as advice. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

38 11RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 35 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jul 15, 2024 at 4:05 PM#33
DebRD_ATL said:
The useful move here is to separate what is established from what is widely repeated.

Same experience, arrived at from the opposite direction. Nothing to add that would improve it.

39 12AttorneyGrant, DebRD_ATL, KristenIndy and 36 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jul 16, 2024 at 12:34 AM#34
DebRD_ATL said:
The useful move here is to separate what is established from what is widely repeated.

There is a second half to this that has not been said yet. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Jul 16, 2024 at 5:34 AM
40 13dan_philly, MeganSA_TX, LarryQC_SD and 37 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jul 16, 2024 at 9:03 AM#35

One concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Jul 16, 2024 at 1:03 PM
41 14Dr.DermMIA, fiona_VT, denise_HTX and 38 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register